Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 4.05 USD 2.79%
Updated: Jun 3, 2024
DSGN
/
Balance Sheet
/
Accrued Liabilities

Design Therapeutics Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Design Therapeutics Inc
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Design Therapeutics Inc
NASDAQ:DSGN
Accrued Liabilities
$7.7m
CAGR 3-Years
104%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
$5.4B
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
8%
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$14.1B
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
$2.8B
CAGR 3-Years
22%
CAGR 5-Years
39%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.4B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
28%

See Also

What is Design Therapeutics Inc's Accrued Liabilities?
Accrued Liabilities
7.7m USD

Based on the financial report for Dec 31, 2023, Design Therapeutics Inc's Accrued Liabilities amounts to 7.7m USD.

What is Design Therapeutics Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
104%

Over the last year, the Accrued Liabilities growth was -2%. The average annual Accrued Liabilities growth rates for Design Therapeutics Inc have been 104% over the past three years .

ALPHA SPREAD
Join more than 143,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.